PTC Inc. (PTC)
PTC Inc. (PTC) is a Top-Ranked Growth Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
uniQure: A Buy For Their Lead In Huntington's Program, In Light Of PTC's Data
uniQure's lead program for Huntington's Disease is planning to file an application via the accelerated approval pathway. On Monday, May 5th, PTC Therapeutics announced positive results from their phase 2 Huntington's Disease trial. I compare the data from these two treatments and share my thoughts here.
PTC's Q2 Earnings & Revenues Top, Improve Y/Y, 2025 Outlook Tweaked
PTC's Q2 performance is driven by solid recurring revenues amid a tough sales backdrop. Fiscal 2025 view is revised based on potential macro volatility.
PTC Inc. (PTC) Q2 2025 Earnings Call Transcript
PTC Inc. (NASDAQ:PTC ) Q3 2025 Earnings Conference Call April 30, 2025 5:00 PM ET Company Participants Matt Shimao - Head of Investor Relations Neil Barua - President & Chief Executive Officer Kristian Talvitie - Chief Financial Officer Robert Dahdah - Executive Vice President & Chief Revenue Officer Conference Call Participants Daniel Jester - BMO Capital Markets Adam Borg - Stifel Saket Kalia - Barclays Siti Panigrahi - Mizuho Securities Co., Ltd. Ken Wong - Oppenheimer & Co. Inc. Jason Celino - KeyBanc Capital Markets Inc. Jay Vleeschhouwer - Griffin Securities, Inc. Nay Soe Naing - Berenberg Joshua Tilton - Wolfe Research Operator Good afternoon, ladies and gentlemen.
Compared to Estimates, PTC Inc. (PTC) Q2 Earnings: A Look at Key Metrics
The headline numbers for PTC Inc. (PTC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
PTC Inc. (PTC) Surpasses Q2 Earnings and Revenue Estimates
PTC Inc. (PTC) came out with quarterly earnings of $1.79 per share, beating the Zacks Consensus Estimate of $1.38 per share. This compares to earnings of $1.46 per share a year ago.
PTC Gearing Up to Report Q2 Earnings: Here's What to Expect
PTC's Q2 performance is likely to have benefited from momentum across its PLM and CAD solutions, though competition and tough selling environment remain concerns.
Why PTC Inc. (PTC) is Poised to Beat Earnings Estimates Again
PTC Inc. (PTC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
PTC Inc. (PTC) Expected to Beat Earnings Estimates: Should You Buy?
PTC Inc. (PTC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PTC Expands Onshape Portfolio to Transform Product Design & Compliance
PTC introduces Onshape AI Advisor and Onshape Government for designers, engineers, educators and professionals in regulated industries.
PTC Launches Codebeamer 3.0 to Boost Speed, Quality & Sustainability
PTC launches Codebeamer 3.0 to speed up product development, boost sustainability and ensure quality and compliance with full traceability and smarter tools.
PTC Therapeutics says European Commission will remove muscle disorder drug
PTC Therapeutics said on Friday the European Commission will remove its inherited progressive muscle-wasting disorder from the region after an advisory panel reaffirmed a negative opinion of the drug in January.
